116 results match your criteria: "Altitude-Related Disorders"
High-altitude regions pose distinctive challenges for cardiovascular health because of decreased oxygen levels, reduced barometric pressure, and colder temperatures. Approximately 82 million people live above 2400 meters, while over 100 million people visit these heights annually. Individuals ascending rapidly or those with pre-existing cardiovascular conditions are particularly vulnerable to altitude-related illnesses, including Acute Mountain Sickness (AMS) and Chronic Mountain Sickness (CMS).
View Article and Find Full Text PDFAmyotroph Lateral Scler Frontotemporal Degener
November 2024
Institute for Breathing and Sleep, Heidelberg, Australia.
Objective: People living with MND (PlwMND) are at risk of altitude-related hypoxia during flight. The Hypoxic Challenge Test (HCT) determines whether in-flight oxygen is required but can be expensive and inaccessible. To assist with travel recommendations, we investigated the relationship between altitude simulation-induced hypoxemia and baseline lung function.
View Article and Find Full Text PDFAnn Med
December 2024
Shigatse Branch, Xinqiao Hospital, Army Medical University, Shigatse, China.
Introduction: RESLES (Reversible splenial lesion syndrome) can be observed secondary to various diseases, and intramyelinic edema may play a crucial role in the pathogenesis of SCC (Splenium of the corpus callosum). Some studies have suggested that hypoxic-ischaemic encephalopathy may constitute a risk factor for SCC lesions. However, the potential impact of high-altitude environments on SCC, especially during chronic exposure, remain obscure.
View Article and Find Full Text PDFCurr Opin Pulm Med
September 2024
Pulmonology
July 2024
Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland; Swiss-Kyrgyz High-Altitude Medicine and Research Initiative, Zurich, Bishkek, Switzerland, Kyrgyz Republic; Research Department, Swiss University for Traditional Chinese Medicine, Bad Zurzach, Switzerland. Electronic address:
J Physiol
November 2024
University Hospital of Zurich, Zurich, Switzerland.
J Physiol
November 2024
Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2 laboratory, Grenoble, France.
Exposure to chronic hypobaric hypoxia imposes a significant physiological burden to more than 80 million humans living above 2500 m throughout the world. Among them, 50 000 live in the world's highest city, La Rinconada, located at 5000-5300 m in southern Peru. Expedition 5300 is the first scientific and medical programme led in La Rinconada to investigate the physiological adaptations and altitude-related health issues in this unique population.
View Article and Find Full Text PDFHigh Alt Med Biol
March 2024
Mental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
High Alt Med Biol
September 2023
Department of Respiratory Medicine, University Hospital Zurich, Zurich, Switzerland.
Clin Exp Hypertens
December 2023
Department of Cardiology, The General Hospital of Western Theater Command, Chengdu, China.
Curr Probl Cardiol
January 2024
Department of Cardiovascular Medicine, Cardiovascular Analytics Group, Islamabad, Pakistan. Electronic address:
Altitude-related venous thrombosis (ARVT) is a condition of growing concern among individuals engaged in high-altitude travel and activities. This updated review explores the epidemiology, pathophysiological mechanisms, clinical presentations, and management of ARVT based on a thematic analysis and synthesis of the existing literature. ARVT's multifactorial etiology involves the interplay of hypobaric hypoxia and endothelial dysfunction, creating a procoagulant state and increasing the risk of thrombosis.
View Article and Find Full Text PDFFront Vet Sci
July 2023
Key Laboratory of Animal Nutrition and Feed Science of Yunnan Province, Yunnan Agricultural University, Kunming, China.
The diversity and abundance of rumen microorganisms serve as indicators not only of the host's digestive and metabolic capacity but also of its health status. The complex microbial communities in the rumen are influenced to varying degrees by environmental adaptability. In this study, we collected 24 rumen fluid samples from 24 healthy male cattle in three regions of Yunnan, China.
View Article and Find Full Text PDFAnn Am Thorac Soc
August 2023
Centre for Heart, Lung and Vascular Health, School of Health and Exercise Sciences, University of British Columbia, Kelowna, British Columbia, Canada.
Central sleep apnea (CSA) is pervasive during sleep at high altitude, disproportionately impacting men and associated with increased peripheral chemosensitivity. We aimed to assess whether biological sex affects loop gain (LGn) and CSA severity during sleep over 9-10 days of acclimatization to 3,800 m. We hypothesized that CSA severity would worsen with acclimatization in men but not in women because of greater increases in LGn in men.
View Article and Find Full Text PDFJ Nepal Health Res Counc
March 2023
Humla District Hospital, Humla, Nepal.
Background: High altitude pilgrims typically ascend rapidly, are not well prepared for the austere environment and tend to have multiple co-morbidities. Here, we list the trend of altitude and other illnesses who visited Humla district hospital (2,950 meters) following very rapid ascent to Kailash Mansarovar (4,500 meters).
Methods: A prospective study was conducted among 55 patients at the Humla District Hospital from September 2019 - August 2022.
Arch Biochem Biophys
October 2022
Institute of Special Environmental Medicine, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong, China. Electronic address:
Blood
November 2022
Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology-The Chinese University of Hong Kong Joint Laboratory of Bioresources and Molecular Research in Common Diseases, National Resource Center for Non-Human Primates, Kunming Primate Research Center, National Research Facility for Phenotypic and Genetic Analysis of Model Animals (Primate Facility), Sino-African Joint Research Center, and Engineering Laboratory of Peptides, Kunming Institute of Zoology, Kunming, China.
High Alt Med Biol
September 2022
Pulmonary Division and Sleep Disorders Center, University Hospital of Zurich, Zurich, Switzerland.
Ulrich, Silvia, Mona Lichtblau, Simon R. Schneider, Stéphanie Saxer, and Konrad E. Bloch, Clinician's corner: counseling patients with pulmonary vascular disease traveling to high altitude.
View Article and Find Full Text PDFFront Pharmacol
May 2022
Department of Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, Delhi, India.
Dexamethasone can be taken prophylactically to prevent hypobaric hypoxia-associated disorders of high-altitude. While dexamethasone-mediated protection against high-altitude disorders has been clinically evaluated, detailed sex-based mechanistic insights have not been explored. As part of our India-Leh-Dexamethasone-expedition-2020 (INDEX 2020) programme, we examined the phenotype of control ( = 14) and dexamethasone ( = 13) groups, which were airlifted from Delhi (∼225 m elevation) to Leh, Ladakh (∼3,500 m), India, for 3 days.
View Article and Find Full Text PDFBMC Pulm Med
May 2022
Service de pneumologie, Centre Hospitalier du Valais Romand, Avenue du Grand-Champsec 80, 1950, Sion, Switzerland.
Int J Gen Med
March 2022
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.
Nat Ecol Evol
May 2022
Center for Evolution and Medicine, Arizona State University, Tempe, AZ, USA.
Sci China Life Sci
October 2022
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Molecules
January 2022
Department of Pharmaceutical Chemistry & Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Uniazah 51911, Saudi Arabia.
Int J Chron Obstruct Pulmon Dis
March 2022
Department of Pulmonology and Sleep Disorders Centre, University Hospital Zurich, Zurich, Switzerland.
NEJM Evid
January 2022
Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland.
BACKGROUND: We evaluated the efficacy of acetazolamide in preventing adverse altitude effects in patients with moderate to severe chronic obstructive pulmonary disease (COPD) and in healthy lowlanders 40 years of age or older. METHODS: Trial 1 was a randomized, double-blind, parallel-design trial in which 176 patients with COPD were treated with acetazolamide capsules (375 mg/day) or placebo, starting 24 hours before staying for 2 days at 3100 m. The mean (±SD) age of participants was 57±9 years, and 34% were women.
View Article and Find Full Text PDF